NASDAQ : NNOX
Nano-X Imaging Ltd. — Key statistics
Healthcare · Medical Devices · Israel
Last price 0.3301 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 23.13M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 22.45M |
| Enterprise Value | -848,347 |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 70.06M |
| Shares Outstanding | 70.06M |
| Shares Change (YoY) | +9.91% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 8.76% |
| Owned by Institutions (%) | 13.77% |
| Float | 62.92M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.43 |
| Forward PS | 0.76 |
| PB Ratio | 0.32 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.84 |
| Quick Ratio | 2.40 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -98.98% |
| Return on Assets (ROA) | -27.86% |
| Return on Invested Capital (ROIC) | -30.49% |
| Return on Capital Employed (ROCE) | -79.25% |
| Weighted Average Cost of Capital (WACC) | 8.33% |
| Revenue Per Employee | $79,355 |
| Profits Per Employee | -$592,939 |
| Employee Count | 197 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 9.77 |
Taxes
| Measure | Value |
|---|
| Income Tax | -1.76M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -90.78% |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 24.11 |
| Average Volume (20 Days) | 872,558 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6.10M |
| Short Previous Month | 6.30M |
| Short % of Shares Out | 8.71% |
| Short % of Float | 9.69% |
| Short Ratio (days to cover) | 7.13 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 15.63M |
| Gross Profit | -12.07M |
| Operating Income | -61.39M |
| Pretax Income | -118.57M |
| Net Income | -116.81M |
| EBITDA | -49.95M |
| EBIT | -61.39M |
| Loss Per Share | -$1.72 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 31.02M |
| Total Debt | 7.73M |
| Net Cash | 23.30M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 72.47M |
| Book Value Per Share | 1.03 |
| Working Capital | 25.27M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -46.70M |
| Capital Expenditures | -5.39M |
| Depreciation & Amortization | 11.44M |
| Net Borrowing | n/a |
| Free Cash Flow | -52.09M |
| FCF Per Share | -$0.74 |
Margins
| Measure | Value |
|---|
| Gross Margin | -77.18% |
| Operating Margin | -392.71% |
| Pretax Margin | -758.47% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -9.91% |
| Shareholder Yield | -9.91% |
| Earnings Yield | -538.18% |
| FCF Yield | -232.35% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.13 |
| Price Target Difference | 1,189.95% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 56.92% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -2.96 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |